Vildagliptin Teva 50 mg tabletes Letland - lettisk - Zāļu valsts aģentūra

vildagliptin teva 50 mg tabletes

teva b.v., netherlands - vildagliptīns - tablete - 50 mg

Vildagliptin Unifarma 50 mg tabletes Letland - lettisk - Zāļu valsts aģentūra

vildagliptin unifarma 50 mg tabletes

unifarma, sia, latvia - vildagliptīns - tablete - 50 mg

Galvus Den Europæiske Union - lettisk - EMA (European Medicines Agency)

galvus

novartis europharm limited - vildagliptin - cukura diabēts, 2. tips - cukura diabēts - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Jalra Den Europæiske Union - lettisk - EMA (European Medicines Agency)

jalra

novartis europharm limited - vildagliptin - cukura diabēts, 2. tips - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 un 5. 1 pieejamo datu par dažādām kombinācijām).

Xiliarx Den Europæiske Union - lettisk - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - vildagliptin - cukura diabēts, 2. tips - cukura diabēts - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 un 5. 1 pieejamo datu par dažādām kombinācijām).

Daltex 50 mg/850 mg apvalkotās tabletes Letland - lettisk - Zāļu valsts aģentūra

daltex 50 mg/850 mg apvalkotās tabletes

medochemie ltd., cyprus - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Daltex 50 mg/1000 mg apvalkotās tabletes Letland - lettisk - Zāļu valsts aģentūra

daltex 50 mg/1000 mg apvalkotās tabletes

medochemie ltd., cyprus - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg

Ipinzan 50 mg/850 mg apvalkotās tabletes Letland - lettisk - Zāļu valsts aģentūra

ipinzan 50 mg/850 mg apvalkotās tabletes

zentiva, k.s., czech republic - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Ipinzan 50 mg/1000 mg apvalkotās tabletes Letland - lettisk - Zāļu valsts aģentūra

ipinzan 50 mg/1000 mg apvalkotās tabletes

zentiva, k.s., czech republic - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg

Vimetso 50 mg/850 mg apvalkotās tabletes Letland - lettisk - Zāļu valsts aģentūra

vimetso 50 mg/850 mg apvalkotās tabletes

krka, d.d., novo mesto, slovenia - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg